Europe Precision Medicine Market Forecast 2021-2028

Publisher Name :
Date: 05-Mar-2021
No. of pages: 188

KEY FINDINGS

The Europe precision medicine market is anticipated to record a CAGR of 9.92%, during the forecast years of 2021 to 2028. The region's market growth is driven by chief factors, including, the government initiatives associated with precision medicine, the surging healthcare expenditure, and the growing focus on eradicating chronic diseases.

MARKET INSIGHTS

The Europe precision medicine market growth is assessed by evaluating Russia, Germany, the United Kingdom, France, Belgium, Poland, Italy, and the rest of Europe. Germany is among the key emerging European countries, in terms of precision medicine. The medical model enjoys increased traction and priority across the Health Research Framework Program, of the German Federal Government. The Federal Research Ministry has provided nearly EUR 360 million in funding, since 2013, for research projects as well as the implementation of precision medicine. Similarly, the ministry also initiated national funding of EUR 1.5 million for ERA-Net PerMed.

On the other hand, France has been taking steps towards developing precision medicine, as the concept continues gaining momentum in the country. Besides, as one of the nations under the Precision Medicine Association in Europe, France plays an important role in augmenting the market growth by offering human resources for related clinical studies. For instance, patients from seven French hospitals were included in an extensive study, termed SHIVA clinical trials, in 2016. They constituted a randomized proof-of-concept Phase II trial, distinguishing molecular targeted therapy, on the basis of tumor molecular profiling, versus conventional treatment in refractory cancer patients. As a result, these factors are anticipated to propel the market growth in Europe, during the forecasted period.

COMPETITIVE INSIGHTS

Leading companies operating in the region's market are, Novartis AG, Intomics, Eagle Genomics Ltd, Qiagen, etc.

Our report offerings include:

- Explore key findings of the overall market

- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

- Market Segmentation cater to a thorough assessment of key segments with their market estimations

- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Europe Precision Medicine Market Forecast 2021-2028

Table Of Contents

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Development Of Precision Medicine
3.2. Key Drivers
3.2.1. Usage Of Digital Collaboration In Exchanging Useful Information For Developing Precision Medicine
3.2.2. Identification And Characterization Of Essential Genes In The Human Genome
3.2.3. Investments By Government And Private Players To Find Effective Treatments For Different Types Of Cancers
3.2.4. Prevalence Of Precision Medicine To Tackle Chronic Conditions
3.2.5. Demand For Preventive Care
3.3. Key Restraints
3.3.1. Security Risks Associated With Data Sharing
3.3.2. Difficulty In Acquiring Pharmacotherapy Approval For A New Drug
3.3.3. Uncertainty Associated With Reimbursement And Regulatory Policies
4. Key Analytics
4.1. Impact Of Covid-19 On Precision Medicine Market
4.2. Key Investment Insights
4.3. Porter's Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entries
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Technologies Related To Precision Medicine
4.7. Supply Chain Analysis
5. Market By Application
5.1. Oncology
5.2. Infectious Diseases
5.3. Neurology/Physiatry
5.4. Cardiovascular
5.5. Lifestyle And Endocrinology
5.6. Gastroenterology
5.7. Other Applications
6. Market By Component
6.1. Applied Science
6.1.1. Genomics
6.1.1.1. Pcr
6.1.1.2. Pm Ngs
6.1.1.3. Genome Editing
6.1.1.4. Other Genomics Technologies
6.1.2. Pharmacogenomics
6.1.3. Other Applied Sciences
6.2. Precision Therapeutics
6.2.1. Clinical Trials
6.2.2. Cell Therapy
6.2.3. Drug Discovery And Research
6.2.4. Gene Therapy
6.3. Precision Diagnostics
6.3.1. Molecular Diagnostics
6.3.1.1. Non-Invasive Prenatal Testing (Nipt)
6.3.1.2. Companion Diagnostics
6.3.1.3. Liquid Biopsy
6.3.1.4. Other Molecular Diagnostics
6.3.2. Medical Imaging
6.3.2.1. Imaging Analytics
6.3.2.2. Imaging Computer-Aided Detection (Cadx)
6.4. Digital Health And Information Technology
6.4.1. Clinical Decision Support Systems (Cdss)
6.4.2. Big Data Analytics
6.4.3. It Infrastructure
6.4.4. Genomics Informatics
6.4.5. In-Silico Informatics
6.4.6. Mobile Health
7. Geographical Analysis
7.1. Europe
7.1.1. Market Size & Estimates
7.1.2. Key Growth Enablers
7.1.3. Key Challenges
7.1.4. Key Players
7.1.5. Country Analysis
7.1.5.1. Germany
7.1.5.2. France
7.1.5.3. United Kingdom
7.1.5.4. Italy
7.1.5.5. Russia
7.1.5.6. Belgium
7.1.5.7. Poland
7.1.5.8. Rest Of Europe
8. Competitive Landscape
8.1. Key Strategic Developments
8.1.1. Mergers & Acquisitions
8.1.2. Product Launches & Developments
8.1.3. Partnerships, Contracts/Agreements & Collaborations
8.1.4. Business Expansions/ Approvals/ Announcements
8.2. Company Profiles
8.2.1. Abbott Laboratories
8.2.2. Astra Zeneca Plc
8.2.3. Biocrates Life Sciences Ag
8.2.4. Bio-Rad Laboratories Inc
8.2.5. Danaher Corporation
8.2.6. Eagle Genomics Ltd
8.2.7. Eli Lilly & Company
8.2.8. F. Hoffmann-La Roche
8.2.9. Intomics
8.2.10. Laboratory Corporation Of America Holdings
8.2.11. Nanostring Technologies
8.2.12. Novartis Ag
8.2.13. Pfizer Inc
8.2.14. Qiagen Nv
8.2.15. Quest Diagnostics Incorporated

List Of Tables
Table 1: Market Snapshot - Precision Medicine
Table 2: Europe Precision Medicine Market, By Application, Historical Years, 2016-2020 (In $ Million)
Table 3: Europe Precision Medicine Market, By Application, Forecast Years, 2021-2028 (In $ Million)
Table 4: Europe Precision Medicine Market, By Component, Historical Years, 2016-2020 (In $ Million)
Table 5: Europe Precision Medicine Market, By Component, Forecast Years, 2021-2028 (In $ Million)
Table 6: Europe Applied Science Market, By Type, Historical Years, 2016-2020 (In $ Million)
Table 7: Europe Applied Science Market, By Type, Forecast Years, 2021-2028 (In $ Million)
Table 8: Europe Genomics Market, By Type, Historical Years, 2016-2020 (In $ Million)
Table 9: Europe Genomics Market, By Type, Forecast Years, 2021-2028 (In $ Million)
Table 10: Europe Precision Therapeutics Market, By Type, Historical Years, 2016-2020 (In $ Million)
Table 11: Europe Precision Therapeutics Market, By Type, Forecast Years, 2021-2028 (In $ Million)
Table 12: Europe Precision Diagnostics Market, By Type, Historical Years, 2016-2020 (In $ Million)
Table 13: Europe Precision Diagnostics Market, By Type, Forecast Years, 2021-2028 (In $ Million)
Table 14: Europe Molecular Diagnostics Market, By Type, Historical Years, 2016-2020 (In $ Million)
Table 15: Europe Molecular Diagnostics Market, By Type, Forecast Years, 2021-2028 (In $ Million)
Table 16: Europe Medical Imaging Market, By Type, Historical Years, 2016-2020 (In $ Million)
Table 17: Europe Medical Imaging Market, By Type, Forecast Years, 2021-2028 (In $ Million)
Table 18: Europe Digital Health And Information Technology Market, By Type, Historical Years, 2016-2020 (In $ Million)
Table 19: Europe Digital Health And Information Technology Market, By Type, Forecast Years, 2021-2028 (In $ Million
Table 20: Europe Precision Medicine Market, By Country, Historical Years, 2016-2020 (In $ Million)
Table 21: Europe Precision Medicine Market, By Country, Forecast Years, 2021-2028 (In $ Million)
Table 22: Leading Players Operating In Europe Precision Medicine Market
Table 23: List Of Mergers & Acquisitions
Table 24: List Of Products Launches & Developments
Table 25: List Of Partnerships & Agreements
Table 26: List Of Business Expansions & Divestitures

List Of Figures
Figure 1: Key Investment Insights
Figure 2: Porter's Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Europe Precision Medicine Market, By Application, In 2020
Figure 6: Europe Precision Medicine Market, By Oncology, 2021-2028 (In $ Million)
Figure 7: Europe Precision Medicine Market, By Infectious Diseases, 2021-2028 (In $ Million)
Figure 8: Europe Precision Medicine Market, By Neurology/Physiatry, 2021-2028 (In $ Million)
Figure 9: Europe Precision Medicine Market, By Cardiovascular, 2021-2028 (In $ Million)
Figure 10: Europe Precision Medicine Market, By Lifestyle And Endocrinology, 2021-2028 (In $ Million)
Figure 11: Europe Precision Medicine Market, By Gastroenterology, 2021-2028 (In $ Million)
Figure 12: Europe Precision Medicine Market, By Other Applications,2021-2028 (In $ Million)
Figure 13: Europe Precision Medicine Market, By Component, In 2020
Figure 14: Europe Precision Medicine Market, By Applied Science, 2021-2028 (In $ Million)
Figure 15: Europe Applied Science Market, By Genomics, 2021-2028 (In $ Million)
Figure 16: Europe Genomics Market, By Pcr, 2021-2028 (In $ Million)
Figure 17: Europe Genomics Market, By Pm Ngs, 2021-2028 (In $ Million)
Figure 18: Europe Genomics Market, By Genome Editing, 2021-2028 (In $ Million)
Figure 19: Europe Genomics Market, By Other Genomics Technologies, 2021-2028 (In $ Million)
Figure 20: Europe Applied Science Market, By Pharmacogenomics, 2021-2028 (In $ Million)
Figure 21: Biomarker's Role In Pharmacogenomics
Figure 22: Europe Applied Sciences Market, By Other Applied Sciences, 2021-2028 (In $ Million)
Figure 23: Europe Precision Medicine Market, By Precision Therapeutics, 2021-2028 (In $ Million)
Figure 24: Europe Precision Therapeutics Market, By Clinical Trials, 2021-2028 (In $ Million)
Figure 25: Europe Precision Therapeutics Market, By Cell Therapy, 2021-2028 (In $ Million)
Figure 26: Europe Precision Therapeutics Market, By Drug Discovery And Research, 2021-2028 (In $ Million)
Figure 27: Europe Precision Therapeutics Market, By Gene Therapy, 2021-2028 (In $ Million)
Figure 28: Europe Precision Medicine Market, By Precision Diagnostics, 2021-2028 (In $ Million)
Figure 29: Europe Precision Diagnostics Market, By Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 30: Europe Molecular Diagnostics Market, By Non-Invasive Prenatal Testing (Nipt), 2021-2028 (In $ Million)
Figure 31: Europe Molecular Diagnostics Market, By Companion Diagnostics, 2021-2028 (In $ Million)
Figure 32: Europe Molecular Diagnostics Market, By Liquid Biopsy, 2021-2028 (In $ Million)
Figure 33: Europe Molecular Diagnostics Market, By Other Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 34: Europe Precision Diagnostics Market, By Medical Imaging, 2021-2028 (In $ Million)
Figure 35: Europe Medical Imaging Market, By Imaging Analytics, 2021-2028 (In $ Million)
Figure 36: Europe Medical Imaging Market, By Imaging Computer-Aided Detection (Cadx), 2021-2028 (In $ Million)
Figure 37: Europe Precision Medicine Market, By Digital Health And Information Technology, 2021-2028 (In $ Million)
Figure 38: Europe Digital Health And Information Technology Market, By Clinical Decision Support Systems (Cdss), 2021-2028 (In $ Million)
Figure 39: Europe Digital Health And Information Technology Market, By Big Data Analytics, 2021-2028 (In $ Million)
Figure 40: Europe Digital Health And Information Technology Market, By It Infrastructure, 2021-2028 (In $ Million)
Figure 41: Europe Digital Health And Information Technology Market, By Genomics Informatics, 2021-2028 (In $ Million)
Figure 42: Europe Digital Health And Information Technology Market, By In-Silico Informatics, 2021-2028 (In $ Million)
Figure 43: Europe Digital Health And Information Technology Market, By Mobile Health, 2021-2028 (In $ Million)
Figure 44: Europe Precision Medicine Market, Country Outlook, 2020 & 2028 (In %)
Figure 45: Germany Precision Medicine Market, 2021-2028 (In $ Million)
Figure 46: France Precision Medicine Market, 2021-2028 (In $ Million)
Figure 47: United Kingdom Precision Medicine Market, 2021-2028 (In $ Million)
Figure 48: Italy Precision Medicine Market, 2021-2028 (In $ Million)
Figure 49: Russia Precision Medicine Market, 2021-2028 (In $ Million)
Figure 50: Belgium Precision Medicine Market, 2021-2028 (In $ Million)
Figure 51: Poland Precision Medicine Market, 2021-2028 (In $ Million)
Figure 52: Rest Of Europe Precision Medicine Market, 2021-2028 (In $ Million)
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs